Follow the NextPlat Corp stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Technology sector, NextPlat Corp has logged 21 reports. Market capitalisation: €18.8m. The latest transaction was reported on 2 July 2026 (Attribution). Among the most active insiders: Barreto Rodney. Every trade is accessible without an account.
Analysts rate NextPlat Corp Strong Buy (bullish), based on 1 analysts. Average price target: US$11.00.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
21 of 21 declarations
NextPlat Corp is a U.S.-listed company trading on the Nasdaq market (NASDAQ: NXPL, NXPLW), placing it squarely in the NYSE/Nasdaq listed-universe, with headquarters in Hallandale Beach, Florida, United States. For French-speaking investors, the company can be viewed as a hybrid growth platform operating at the intersection of e-commerce, healthcare services, and satellite communications. NextPlat presents itself as a global consumer products and services company, using online storefronts, marketplaces, and retail channels to distribute products and services across the U.S. and international markets. ([ir.nextplat.com](https://ir.nextplat.com/?utm_source=openai)) The company’s roots go back to its former identity as Orbsat Corp, and market sources indicate an initial corporate history dating to 1997, while its modern operating footprint was built over time around international e-commerce and satellite communications. NextPlat adopted its current name in 2022. Its platform has been expanded through acquisitions and strategic integrations, notably Progressive Care, which strengthened the healthcare segment, and Outfitter Satellite, which broadened exposure to satellite-enabled products and services in North America. ([stockanalysis.com](https://stockanalysis.com/stocks/nxpl/company/?utm_source=openai)) Operationally, NextPlat now reports three core business lines: healthcare, satellite communications, and global e-commerce. In healthcare, its PharmcoRx subsidiary offers retail pharmacy, 340B program management, and long-term care services. In satellite communications, subsidiaries GTC, OSAT, and OSI provide satellite-enabled voice, data, tracking, and IoT solutions. In global e-commerce, the company helps brands expand online via major marketplaces and Amazon stores, while also supporting international expansion into China through platforms such as Tmall, JD, and Alibaba. The company also highlights global distribution capabilities for customers in the United States and abroad. ([nextplat.com](https://www.nextplat.com/pages/about-us?utm_source=openai)) NextPlat’s competitive positioning is unusual in that it combines digital commerce execution, healthcare distribution, and satellite connectivity in one corporate structure. That diversification can create multiple growth levers, but it also increases integration complexity and makes execution quality critical. Management states that the company serves more than 150,000 customers across 160+ countries and operates through 30+ storefronts, marketplaces, and retail locations, underscoring a meaningful international footprint for a relatively small-cap listed company. ([nextplat.com](https://www.nextplat.com/pages/about-us?utm_source=openai)) Recent developments have centered on turnaround execution and margin improvement. NextPlat reported $65.5 million of consolidated revenue for fiscal 2024 and $54 million of revenue for fiscal 2025, while also emphasizing cost-cutting, refocusing initiatives, and efforts to improve operational profitability. Quarterly disclosures in 2025 and 2026 pointed to improving performance in healthcare and better sequential trends. For investors in the U.S. market, the key question is whether NextPlat can translate its diversified asset base into sustained revenue quality, stronger margins, and eventually more predictable free cash generation. ([nasdaq.com](https://www.nasdaq.com/press-release/nextplat-reports-655-million-consolidated-year-end-2024-revenue-2025-03-24?utm_source=openai))